GILD - Gilead Sciences Inc
This page shows which of the focused investors we track hold GILD and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2018 it was held by 6 managers with an aggregate reported value of $1.6B, which is 0.17% of the combined portfolio.
As of Q3 2018, 6 tracked institutional managers held GILD (Gilead Sciences Inc) with an aggregate reported value of $1.6B — 0.17% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades GILD — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2018
- Ticker
- GILD
13F data is delayed and excludes shorts/non-13F assets.
Long holders
| 1 | Dodge & Cox - Dodge & Cox | 0.98% | Add +1.2% | 16,450,181 | $1.27B |
| 2 | Ariel Investments - Ariel Investments | 2.06% | Add +3.2% | 2,404,049 | $185.62M |
| 3 | Stanley Druckenmiller - Duquesne Family Office LLC | 5.38% | Add +21.5% | 1,464,900 | $113.11M |
| 4 | David Katz - Matrix Asset Advisors | 3.43% | Add +3.4% | 278,396 | $21.5M |
| 5 | Muhlenkamp - Muhlenkamp | 4.50% | Reduce -0.6% | 135,401 | $10.45M |
Call holders — bullish via leverage
1 manager holds call options on GILD — a right to buy at strike. Notional value, not premium.
| 1 | Muhlenkamp - Muhlenkamp | - | 2,200 | $170K |
Loading holder history for GILD…